The EU glucometer market is booming, projected to reach €10.37 billion by 2033, driven by rising diabetes prevalence and CGM adoption. This in-depth analysis explores market size, growth, key players (Medtronic, Abbott, Roche), and regional trends in France, Germany, and more. Discover the latest insights on SMBG and CGM technologies.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.